Adaptyv Raises $40 Million To Build the Automated AI Lab for Agentic Biology
AI can now design thousands of protein molecules in an afternoon. But it’s yet to find a way to determine if they actually work. Most labs were built to test The post Adaptyv Raises $40 Million To Build the Automated AI Lab for Agentic Biology appeared first on Ventureburn .
Adaptyv Bio, a Lausanne-based company, has secured $40 million in Series A funding to develop an automated, AI-native laboratory for agentic biology. The round was led by Highland Europe, with additional investments from Ace Ventures, ByFounders, and Y Combinator. Adaptyv has created a platform that allows AI models to design, test, and learn from thousands of protein molecules at once, bypassing the traditional wet lab process that takes weeks and is costly.
The company's "automated lab" utilizes cell-free protein production, eliminating the need for living cells. Adaptyv's unique AI-powered API enables seamless integration with other tools and allows for autonomous design, testing, and learning cycles. The newly raised funds will be used to expand lab infrastructure, hire additional staff, and open a new lab in London by 2026.
This investment positions Switzerland as a hub for AI-driven protein engineering, with over 55 VC-backed TechBio startups in the region.
Written by urgent.news from Ventureburn's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
